New solutions for the manufacture and analysis of adeno-associated viruses (AAVs) are essential to advance gene therapies.
By tailoring robust assays, biopharma facilities can obtain more accurate and reproducible results and accelerate the progression of their products to the market. This eBook explores the analytical solutions that are accelerating AAV-based gene therapy.Download this eBook to learn how these solutions are being used to optimize:
- AAV characterization and host cell profiling
- AAV titer determination
- Quantitative analysis of genome packaging